Global Live Attenuated Vaccines for Poultry Market Research Report 2026(Status and Outlook)
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly ?6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 612%.
The global Live Attenuated Vaccines for Poultry market size was estimated at USD 368.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Live Attenuated Vaccines for Poultry market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Live Attenuated Vaccines for Poultry market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Live Attenuated Vaccines for Poultry market.
Global Live Attenuated Vaccines for Poultry Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
MERCK
Boehringer Ingelheim
ELANCO
QYH BIOTECH
CEVA
HIPRA
Kemin Biologics
ZOETIS
Vaxxinova
PULIKE
PHIBRO ANIMAL HEALTH CORPORATION
JINYU BIOTECHNOLOGY
HARBIN PHARMACEUTICAL GROUP
MEVAC
Market Segmentation (by Type)
Spray
Eye Drop
Oral
Others
Market Segmentation (by Application)
Chicken
Cattle
Horse
Others
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Live Attenuated Vaccines for Poultry Market
Overview of the regional outlook of the Live Attenuated Vaccines for Poultry Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Live Attenuated Vaccines for Poultry Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Live Attenuated Vaccines for Poultry, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Live Attenuated Vaccines for Poultry market size was estimated at USD 368.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Live Attenuated Vaccines for Poultry market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Live Attenuated Vaccines for Poultry market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Live Attenuated Vaccines for Poultry market.
Global Live Attenuated Vaccines for Poultry Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
MERCK
Boehringer Ingelheim
ELANCO
QYH BIOTECH
CEVA
HIPRA
Kemin Biologics
ZOETIS
Vaxxinova
PULIKE
PHIBRO ANIMAL HEALTH CORPORATION
JINYU BIOTECHNOLOGY
HARBIN PHARMACEUTICAL GROUP
MEVAC
Market Segmentation (by Type)
Spray
Eye Drop
Oral
Others
Market Segmentation (by Application)
Chicken
Cattle
Horse
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Live Attenuated Vaccines for Poultry Market
Overview of the regional outlook of the Live Attenuated Vaccines for Poultry Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Live Attenuated Vaccines for Poultry Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Live Attenuated Vaccines for Poultry, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Live Attenuated Vaccines for Poultry
1.2 Key Market Segments
1.2.1 Live Attenuated Vaccines for Poultry Segment by Type
1.2.2 Live Attenuated Vaccines for Poultry Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LIVE ATTENUATED VACCINES FOR POULTRY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Live Attenuated Vaccines for Poultry Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Live Attenuated Vaccines for Poultry Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LIVE ATTENUATED VACCINES FOR POULTRY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Live Attenuated Vaccines for Poultry Product Life Cycle
3.3 Global Live Attenuated Vaccines for Poultry Sales by Manufacturers (2020-2025)
3.4 Global Live Attenuated Vaccines for Poultry Revenue Market Share by Manufacturers (2020-2025)
3.5 Live Attenuated Vaccines for Poultry Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Live Attenuated Vaccines for Poultry Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Live Attenuated Vaccines for Poultry Market Competitive Situation and Trends
3.8.1 Live Attenuated Vaccines for Poultry Market Concentration Rate
3.8.2 Global 5 and 10 Largest Live Attenuated Vaccines for Poultry Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LIVE ATTENUATED VACCINES FOR POULTRY INDUSTRY CHAIN ANALYSIS
4.1 Live Attenuated Vaccines for Poultry Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LIVE ATTENUATED VACCINES FOR POULTRY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Live Attenuated Vaccines for Poultry Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Live Attenuated Vaccines for Poultry Market
5.7 ESG Ratings of Leading Companies
6 LIVE ATTENUATED VACCINES FOR POULTRY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Live Attenuated Vaccines for Poultry Sales Market Share by Type (2020-2025)
6.3 Global Live Attenuated Vaccines for Poultry Market Size by Type (2020-2025)
6.4 Global Live Attenuated Vaccines for Poultry Price by Type (2020-2025)
7 LIVE ATTENUATED VACCINES FOR POULTRY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Live Attenuated Vaccines for Poultry Market Sales by Application (2020-2025)
7.3 Global Live Attenuated Vaccines for Poultry Market Size (M USD) by Application (2020-2025)
7.4 Global Live Attenuated Vaccines for Poultry Sales Growth Rate by Application (2020-2025)
8 LIVE ATTENUATED VACCINES FOR POULTRY MARKET SALES BY REGION
8.1 Global Live Attenuated Vaccines for Poultry Sales by Region
8.1.1 Global Live Attenuated Vaccines for Poultry Sales by Region
8.1.2 Global Live Attenuated Vaccines for Poultry Sales Market Share by Region
8.2 Global Live Attenuated Vaccines for Poultry Market Size by Region
8.2.1 Global Live Attenuated Vaccines for Poultry Market Size by Region
8.2.2 Global Live Attenuated Vaccines for Poultry Market Size by Region
8.3 North America
8.3.1 North America Live Attenuated Vaccines for Poultry Sales by Country
8.3.2 North America Live Attenuated Vaccines for Poultry Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Live Attenuated Vaccines for Poultry Sales by Country
8.4.2 Europe Live Attenuated Vaccines for Poultry Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Live Attenuated Vaccines for Poultry Sales by Region
8.5.2 Asia Pacific Live Attenuated Vaccines for Poultry Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Live Attenuated Vaccines for Poultry Sales by Country
8.6.2 South America Live Attenuated Vaccines for Poultry Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Live Attenuated Vaccines for Poultry Sales by Region
8.7.2 Middle East and Africa Live Attenuated Vaccines for Poultry Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LIVE ATTENUATED VACCINES FOR POULTRY MARKET PRODUCTION BY REGION
9.1 Global Production of Live Attenuated Vaccines for Poultry by Region(2020-2025)
9.2 Global Live Attenuated Vaccines for Poultry Revenue Market Share by Region (2020-2025)
9.3 Global Live Attenuated Vaccines for Poultry Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Live Attenuated Vaccines for Poultry Production
9.4.1 North America Live Attenuated Vaccines for Poultry Production Growth Rate (2020-2025)
9.4.2 North America Live Attenuated Vaccines for Poultry Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Live Attenuated Vaccines for Poultry Production
9.5.1 Europe Live Attenuated Vaccines for Poultry Production Growth Rate (2020-2025)
9.5.2 Europe Live Attenuated Vaccines for Poultry Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Live Attenuated Vaccines for Poultry Production (2020-2025)
9.6.1 Japan Live Attenuated Vaccines for Poultry Production Growth Rate (2020-2025)
9.6.2 Japan Live Attenuated Vaccines for Poultry Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Live Attenuated Vaccines for Poultry Production (2020-2025)
9.7.1 China Live Attenuated Vaccines for Poultry Production Growth Rate (2020-2025)
9.7.2 China Live Attenuated Vaccines for Poultry Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 MERCK
10.1.1 MERCK Basic Information
10.1.2 MERCK Live Attenuated Vaccines for Poultry Product Overview
10.1.3 MERCK Live Attenuated Vaccines for Poultry Product Market Performance
10.1.4 MERCK Business Overview
10.1.5 MERCK SWOT Analysis
10.1.6 MERCK Recent Developments
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Basic Information
10.2.2 Boehringer Ingelheim Live Attenuated Vaccines for Poultry Product Overview
10.2.3 Boehringer Ingelheim Live Attenuated Vaccines for Poultry Product Market Performance
10.2.4 Boehringer Ingelheim Business Overview
10.2.5 Boehringer Ingelheim SWOT Analysis
10.2.6 Boehringer Ingelheim Recent Developments
10.3 ELANCO
10.3.1 ELANCO Basic Information
10.3.2 ELANCO Live Attenuated Vaccines for Poultry Product Overview
10.3.3 ELANCO Live Attenuated Vaccines for Poultry Product Market Performance
10.3.4 ELANCO Business Overview
10.3.5 ELANCO SWOT Analysis
10.3.6 ELANCO Recent Developments
10.4 QYH BIOTECH
10.4.1 QYH BIOTECH Basic Information
10.4.2 QYH BIOTECH Live Attenuated Vaccines for Poultry Product Overview
10.4.3 QYH BIOTECH Live Attenuated Vaccines for Poultry Product Market Performance
10.4.4 QYH BIOTECH Business Overview
10.4.5 QYH BIOTECH Recent Developments
10.5 CEVA
10.5.1 CEVA Basic Information
10.5.2 CEVA Live Attenuated Vaccines for Poultry Product Overview
10.5.3 CEVA Live Attenuated Vaccines for Poultry Product Market Performance
10.5.4 CEVA Business Overview
10.5.5 CEVA Recent Developments
10.6 HIPRA
10.6.1 HIPRA Basic Information
10.6.2 HIPRA Live Attenuated Vaccines for Poultry Product Overview
10.6.3 HIPRA Live Attenuated Vaccines for Poultry Product Market Performance
10.6.4 HIPRA Business Overview
10.6.5 HIPRA Recent Developments
10.7 Kemin Biologics
10.7.1 Kemin Biologics Basic Information
10.7.2 Kemin Biologics Live Attenuated Vaccines for Poultry Product Overview
10.7.3 Kemin Biologics Live Attenuated Vaccines for Poultry Product Market Performance
10.7.4 Kemin Biologics Business Overview
10.7.5 Kemin Biologics Recent Developments
10.8 ZOETIS
10.8.1 ZOETIS Basic Information
10.8.2 ZOETIS Live Attenuated Vaccines for Poultry Product Overview
10.8.3 ZOETIS Live Attenuated Vaccines for Poultry Product Market Performance
10.8.4 ZOETIS Business Overview
10.8.5 ZOETIS Recent Developments
10.9 Vaxxinova
10.9.1 Vaxxinova Basic Information
10.9.2 Vaxxinova Live Attenuated Vaccines for Poultry Product Overview
10.9.3 Vaxxinova Live Attenuated Vaccines for Poultry Product Market Performance
10.9.4 Vaxxinova Business Overview
10.9.5 Vaxxinova Recent Developments
10.10 PULIKE
10.10.1 PULIKE Basic Information
10.10.2 PULIKE Live Attenuated Vaccines for Poultry Product Overview
10.10.3 PULIKE Live Attenuated Vaccines for Poultry Product Market Performance
10.10.4 PULIKE Business Overview
10.10.5 PULIKE Recent Developments
10.11 PHIBRO ANIMAL HEALTH CORPORATION
10.11.1 PHIBRO ANIMAL HEALTH CORPORATION Basic Information
10.11.2 PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Product Overview
10.11.3 PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Product Market Performance
10.11.4 PHIBRO ANIMAL HEALTH CORPORATION Business Overview
10.11.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments
10.12 JINYU BIOTECHNOLOGY
10.12.1 JINYU BIOTECHNOLOGY Basic Information
10.12.2 JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Product Overview
10.12.3 JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Product Market Performance
10.12.4 JINYU BIOTECHNOLOGY Business Overview
10.12.5 JINYU BIOTECHNOLOGY Recent Developments
10.13 HARBIN PHARMACEUTICAL GROUP
10.13.1 HARBIN PHARMACEUTICAL GROUP Basic Information
10.13.2 HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Product Overview
10.13.3 HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Product Market Performance
10.13.4 HARBIN PHARMACEUTICAL GROUP Business Overview
10.13.5 HARBIN PHARMACEUTICAL GROUP Recent Developments
10.14 MEVAC
10.14.1 MEVAC Basic Information
10.14.2 MEVAC Live Attenuated Vaccines for Poultry Product Overview
10.14.3 MEVAC Live Attenuated Vaccines for Poultry Product Market Performance
10.14.4 MEVAC Business Overview
10.14.5 MEVAC Recent Developments
11 LIVE ATTENUATED VACCINES FOR POULTRY MARKET FORECAST BY REGION
11.1 Global Live Attenuated Vaccines for Poultry Market Size Forecast
11.2 Global Live Attenuated Vaccines for Poultry Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Live Attenuated Vaccines for Poultry Market Size Forecast by Country
11.2.3 Asia Pacific Live Attenuated Vaccines for Poultry Market Size Forecast by Region
11.2.4 South America Live Attenuated Vaccines for Poultry Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Live Attenuated Vaccines for Poultry by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Live Attenuated Vaccines for Poultry Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Live Attenuated Vaccines for Poultry by Type (2026-2035)
12.1.2 Global Live Attenuated Vaccines for Poultry Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Live Attenuated Vaccines for Poultry by Type (2026-2035)
12.2 Global Live Attenuated Vaccines for Poultry Market Forecast by Application (2026-2035)
12.2.1 Global Live Attenuated Vaccines for Poultry Sales (K MT) Forecast by Application
12.2.2 Global Live Attenuated Vaccines for Poultry Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Live Attenuated Vaccines for Poultry
1.2 Key Market Segments
1.2.1 Live Attenuated Vaccines for Poultry Segment by Type
1.2.2 Live Attenuated Vaccines for Poultry Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LIVE ATTENUATED VACCINES FOR POULTRY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Live Attenuated Vaccines for Poultry Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Live Attenuated Vaccines for Poultry Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LIVE ATTENUATED VACCINES FOR POULTRY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Live Attenuated Vaccines for Poultry Product Life Cycle
3.3 Global Live Attenuated Vaccines for Poultry Sales by Manufacturers (2020-2025)
3.4 Global Live Attenuated Vaccines for Poultry Revenue Market Share by Manufacturers (2020-2025)
3.5 Live Attenuated Vaccines for Poultry Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Live Attenuated Vaccines for Poultry Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Live Attenuated Vaccines for Poultry Market Competitive Situation and Trends
3.8.1 Live Attenuated Vaccines for Poultry Market Concentration Rate
3.8.2 Global 5 and 10 Largest Live Attenuated Vaccines for Poultry Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LIVE ATTENUATED VACCINES FOR POULTRY INDUSTRY CHAIN ANALYSIS
4.1 Live Attenuated Vaccines for Poultry Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LIVE ATTENUATED VACCINES FOR POULTRY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Live Attenuated Vaccines for Poultry Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Live Attenuated Vaccines for Poultry Market
5.7 ESG Ratings of Leading Companies
6 LIVE ATTENUATED VACCINES FOR POULTRY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Live Attenuated Vaccines for Poultry Sales Market Share by Type (2020-2025)
6.3 Global Live Attenuated Vaccines for Poultry Market Size by Type (2020-2025)
6.4 Global Live Attenuated Vaccines for Poultry Price by Type (2020-2025)
7 LIVE ATTENUATED VACCINES FOR POULTRY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Live Attenuated Vaccines for Poultry Market Sales by Application (2020-2025)
7.3 Global Live Attenuated Vaccines for Poultry Market Size (M USD) by Application (2020-2025)
7.4 Global Live Attenuated Vaccines for Poultry Sales Growth Rate by Application (2020-2025)
8 LIVE ATTENUATED VACCINES FOR POULTRY MARKET SALES BY REGION
8.1 Global Live Attenuated Vaccines for Poultry Sales by Region
8.1.1 Global Live Attenuated Vaccines for Poultry Sales by Region
8.1.2 Global Live Attenuated Vaccines for Poultry Sales Market Share by Region
8.2 Global Live Attenuated Vaccines for Poultry Market Size by Region
8.2.1 Global Live Attenuated Vaccines for Poultry Market Size by Region
8.2.2 Global Live Attenuated Vaccines for Poultry Market Size by Region
8.3 North America
8.3.1 North America Live Attenuated Vaccines for Poultry Sales by Country
8.3.2 North America Live Attenuated Vaccines for Poultry Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Live Attenuated Vaccines for Poultry Sales by Country
8.4.2 Europe Live Attenuated Vaccines for Poultry Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Live Attenuated Vaccines for Poultry Sales by Region
8.5.2 Asia Pacific Live Attenuated Vaccines for Poultry Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Live Attenuated Vaccines for Poultry Sales by Country
8.6.2 South America Live Attenuated Vaccines for Poultry Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Live Attenuated Vaccines for Poultry Sales by Region
8.7.2 Middle East and Africa Live Attenuated Vaccines for Poultry Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LIVE ATTENUATED VACCINES FOR POULTRY MARKET PRODUCTION BY REGION
9.1 Global Production of Live Attenuated Vaccines for Poultry by Region(2020-2025)
9.2 Global Live Attenuated Vaccines for Poultry Revenue Market Share by Region (2020-2025)
9.3 Global Live Attenuated Vaccines for Poultry Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Live Attenuated Vaccines for Poultry Production
9.4.1 North America Live Attenuated Vaccines for Poultry Production Growth Rate (2020-2025)
9.4.2 North America Live Attenuated Vaccines for Poultry Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Live Attenuated Vaccines for Poultry Production
9.5.1 Europe Live Attenuated Vaccines for Poultry Production Growth Rate (2020-2025)
9.5.2 Europe Live Attenuated Vaccines for Poultry Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Live Attenuated Vaccines for Poultry Production (2020-2025)
9.6.1 Japan Live Attenuated Vaccines for Poultry Production Growth Rate (2020-2025)
9.6.2 Japan Live Attenuated Vaccines for Poultry Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Live Attenuated Vaccines for Poultry Production (2020-2025)
9.7.1 China Live Attenuated Vaccines for Poultry Production Growth Rate (2020-2025)
9.7.2 China Live Attenuated Vaccines for Poultry Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 MERCK
10.1.1 MERCK Basic Information
10.1.2 MERCK Live Attenuated Vaccines for Poultry Product Overview
10.1.3 MERCK Live Attenuated Vaccines for Poultry Product Market Performance
10.1.4 MERCK Business Overview
10.1.5 MERCK SWOT Analysis
10.1.6 MERCK Recent Developments
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Basic Information
10.2.2 Boehringer Ingelheim Live Attenuated Vaccines for Poultry Product Overview
10.2.3 Boehringer Ingelheim Live Attenuated Vaccines for Poultry Product Market Performance
10.2.4 Boehringer Ingelheim Business Overview
10.2.5 Boehringer Ingelheim SWOT Analysis
10.2.6 Boehringer Ingelheim Recent Developments
10.3 ELANCO
10.3.1 ELANCO Basic Information
10.3.2 ELANCO Live Attenuated Vaccines for Poultry Product Overview
10.3.3 ELANCO Live Attenuated Vaccines for Poultry Product Market Performance
10.3.4 ELANCO Business Overview
10.3.5 ELANCO SWOT Analysis
10.3.6 ELANCO Recent Developments
10.4 QYH BIOTECH
10.4.1 QYH BIOTECH Basic Information
10.4.2 QYH BIOTECH Live Attenuated Vaccines for Poultry Product Overview
10.4.3 QYH BIOTECH Live Attenuated Vaccines for Poultry Product Market Performance
10.4.4 QYH BIOTECH Business Overview
10.4.5 QYH BIOTECH Recent Developments
10.5 CEVA
10.5.1 CEVA Basic Information
10.5.2 CEVA Live Attenuated Vaccines for Poultry Product Overview
10.5.3 CEVA Live Attenuated Vaccines for Poultry Product Market Performance
10.5.4 CEVA Business Overview
10.5.5 CEVA Recent Developments
10.6 HIPRA
10.6.1 HIPRA Basic Information
10.6.2 HIPRA Live Attenuated Vaccines for Poultry Product Overview
10.6.3 HIPRA Live Attenuated Vaccines for Poultry Product Market Performance
10.6.4 HIPRA Business Overview
10.6.5 HIPRA Recent Developments
10.7 Kemin Biologics
10.7.1 Kemin Biologics Basic Information
10.7.2 Kemin Biologics Live Attenuated Vaccines for Poultry Product Overview
10.7.3 Kemin Biologics Live Attenuated Vaccines for Poultry Product Market Performance
10.7.4 Kemin Biologics Business Overview
10.7.5 Kemin Biologics Recent Developments
10.8 ZOETIS
10.8.1 ZOETIS Basic Information
10.8.2 ZOETIS Live Attenuated Vaccines for Poultry Product Overview
10.8.3 ZOETIS Live Attenuated Vaccines for Poultry Product Market Performance
10.8.4 ZOETIS Business Overview
10.8.5 ZOETIS Recent Developments
10.9 Vaxxinova
10.9.1 Vaxxinova Basic Information
10.9.2 Vaxxinova Live Attenuated Vaccines for Poultry Product Overview
10.9.3 Vaxxinova Live Attenuated Vaccines for Poultry Product Market Performance
10.9.4 Vaxxinova Business Overview
10.9.5 Vaxxinova Recent Developments
10.10 PULIKE
10.10.1 PULIKE Basic Information
10.10.2 PULIKE Live Attenuated Vaccines for Poultry Product Overview
10.10.3 PULIKE Live Attenuated Vaccines for Poultry Product Market Performance
10.10.4 PULIKE Business Overview
10.10.5 PULIKE Recent Developments
10.11 PHIBRO ANIMAL HEALTH CORPORATION
10.11.1 PHIBRO ANIMAL HEALTH CORPORATION Basic Information
10.11.2 PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Product Overview
10.11.3 PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Product Market Performance
10.11.4 PHIBRO ANIMAL HEALTH CORPORATION Business Overview
10.11.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments
10.12 JINYU BIOTECHNOLOGY
10.12.1 JINYU BIOTECHNOLOGY Basic Information
10.12.2 JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Product Overview
10.12.3 JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Product Market Performance
10.12.4 JINYU BIOTECHNOLOGY Business Overview
10.12.5 JINYU BIOTECHNOLOGY Recent Developments
10.13 HARBIN PHARMACEUTICAL GROUP
10.13.1 HARBIN PHARMACEUTICAL GROUP Basic Information
10.13.2 HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Product Overview
10.13.3 HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Product Market Performance
10.13.4 HARBIN PHARMACEUTICAL GROUP Business Overview
10.13.5 HARBIN PHARMACEUTICAL GROUP Recent Developments
10.14 MEVAC
10.14.1 MEVAC Basic Information
10.14.2 MEVAC Live Attenuated Vaccines for Poultry Product Overview
10.14.3 MEVAC Live Attenuated Vaccines for Poultry Product Market Performance
10.14.4 MEVAC Business Overview
10.14.5 MEVAC Recent Developments
11 LIVE ATTENUATED VACCINES FOR POULTRY MARKET FORECAST BY REGION
11.1 Global Live Attenuated Vaccines for Poultry Market Size Forecast
11.2 Global Live Attenuated Vaccines for Poultry Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Live Attenuated Vaccines for Poultry Market Size Forecast by Country
11.2.3 Asia Pacific Live Attenuated Vaccines for Poultry Market Size Forecast by Region
11.2.4 South America Live Attenuated Vaccines for Poultry Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Live Attenuated Vaccines for Poultry by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Live Attenuated Vaccines for Poultry Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Live Attenuated Vaccines for Poultry by Type (2026-2035)
12.1.2 Global Live Attenuated Vaccines for Poultry Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Live Attenuated Vaccines for Poultry by Type (2026-2035)
12.2 Global Live Attenuated Vaccines for Poultry Market Forecast by Application (2026-2035)
12.2.1 Global Live Attenuated Vaccines for Poultry Sales (K MT) Forecast by Application
12.2.2 Global Live Attenuated Vaccines for Poultry Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Live Attenuated Vaccines for Poultry Market Size by Type (M USD)
Table 4. Global Live Attenuated Vaccines for Poultry Market Size by Application
Table 5. Live Attenuated Vaccines for Poultry Market Size Comparison by Region (M USD)
Table 6. Global Live Attenuated Vaccines for Poultry Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Live Attenuated Vaccines for Poultry Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Live Attenuated Vaccines for Poultry Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Live Attenuated Vaccines for Poultry Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Vaccines for Poultry as of 2025)
Table 11. Global Market Live Attenuated Vaccines for Poultry Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Live Attenuated Vaccines for Poultry Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Live Attenuated Vaccines for Poultry Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Live Attenuated Vaccines for Poultry Sales by Type (K MT)
Table 27. Global Live Attenuated Vaccines for Poultry Market Size by Type (M USD)
Table 28. Global Live Attenuated Vaccines for Poultry Sales (K MT) by Type (2020-2025)
Table 29. Global Live Attenuated Vaccines for Poultry Sales Market Share by Type (2020-2025)
Table 30. Global Live Attenuated Vaccines for Poultry Market Size (M USD) by Type (2020-2025)
Table 31. Global Live Attenuated Vaccines for Poultry Market Share by Type (2020-2025)
Table 32. Global Live Attenuated Vaccines for Poultry Price (USD/KG) by Type (2020-2025)
Table 33. Global Live Attenuated Vaccines for Poultry Sales (K MT) by Application
Table 34. Global Live Attenuated Vaccines for Poultry Market Size by Application
Table 35. Global Live Attenuated Vaccines for Poultry Sales by Application (2020-2025) & (K MT)
Table 36. Global Live Attenuated Vaccines for Poultry Sales Market Share by Application (2020-2025)
Table 37. Global Live Attenuated Vaccines for Poultry Market Size by Application (2020-2025) & (M USD)
Table 38. Global Live Attenuated Vaccines for Poultry Market Share by Application (2020-2025)
Table 39. Global Live Attenuated Vaccines for Poultry Sales Growth Rate by Application (2020-2025)
Table 40. Global Live Attenuated Vaccines for Poultry Sales by Region (2020-2025) & (K MT)
Table 41. Global Live Attenuated Vaccines for Poultry Sales Market Share by Region (2020-2025)
Table 42. Global Live Attenuated Vaccines for Poultry Market Size by Region (2020-2025) & (M USD)
Table 43. Global Live Attenuated Vaccines for Poultry Market Size by Region (2020-2025)
Table 44. North America Live Attenuated Vaccines for Poultry Sales by Country (2020-2025) & (K MT)
Table 45. North America Live Attenuated Vaccines for Poultry Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Live Attenuated Vaccines for Poultry Sales by Country (2020-2025) & (K MT)
Table 47. Europe Live Attenuated Vaccines for Poultry Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Live Attenuated Vaccines for Poultry Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Live Attenuated Vaccines for Poultry Market Size by Region (2020-2025) & (M USD)
Table 50. South America Live Attenuated Vaccines for Poultry Sales by Country (2020-2025) & (K MT)
Table 51. South America Live Attenuated Vaccines for Poultry Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Live Attenuated Vaccines for Poultry Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Live Attenuated Vaccines for Poultry Market Size by Region (2020-2025) & (M USD)
Table 54. Global Live Attenuated Vaccines for Poultry Production (K MT) by Region(2020-2025)
Table 55. Global Live Attenuated Vaccines for Poultry Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Live Attenuated Vaccines for Poultry Revenue Market Share by Region (2020-2025)
Table 57. Global Live Attenuated Vaccines for Poultry Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Live Attenuated Vaccines for Poultry Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Live Attenuated Vaccines for Poultry Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Live Attenuated Vaccines for Poultry Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Live Attenuated Vaccines for Poultry Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. MERCK Basic Information
Table 63. MERCK Live Attenuated Vaccines for Poultry Product Overview
Table 64. MERCK Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. MERCK Business Overview
Table 66. MERCK SWOT Analysis
Table 67. MERCK Recent Developments
Table 68. Boehringer Ingelheim Basic Information
Table 69. Boehringer Ingelheim Live Attenuated Vaccines for Poultry Product Overview
Table 70. Boehringer Ingelheim Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim SWOT Analysis
Table 73. Boehringer Ingelheim Recent Developments
Table 74. ELANCO Basic Information
Table 75. ELANCO Live Attenuated Vaccines for Poultry Product Overview
Table 76. ELANCO Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. ELANCO Business Overview
Table 78. ELANCO SWOT Analysis
Table 79. ELANCO Recent Developments
Table 80. QYH BIOTECH Basic Information
Table 81. QYH BIOTECH Live Attenuated Vaccines for Poultry Product Overview
Table 82. QYH BIOTECH Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. QYH BIOTECH Business Overview
Table 84. QYH BIOTECH Recent Developments
Table 85. CEVA Basic Information
Table 86. CEVA Live Attenuated Vaccines for Poultry Product Overview
Table 87. CEVA Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. CEVA Business Overview
Table 89. CEVA Recent Developments
Table 90. HIPRA Basic Information
Table 91. HIPRA Live Attenuated Vaccines for Poultry Product Overview
Table 92. HIPRA Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. HIPRA Business Overview
Table 94. HIPRA Recent Developments
Table 95. Kemin Biologics Basic Information
Table 96. Kemin Biologics Live Attenuated Vaccines for Poultry Product Overview
Table 97. Kemin Biologics Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Kemin Biologics Business Overview
Table 99. Kemin Biologics Recent Developments
Table 100. ZOETIS Basic Information
Table 101. ZOETIS Live Attenuated Vaccines for Poultry Product Overview
Table 102. ZOETIS Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. ZOETIS Business Overview
Table 104. ZOETIS Recent Developments
Table 105. Vaxxinova Basic Information
Table 106. Vaxxinova Live Attenuated Vaccines for Poultry Product Overview
Table 107. Vaxxinova Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Vaxxinova Business Overview
Table 109. Vaxxinova Recent Developments
Table 110. PULIKE Basic Information
Table 111. PULIKE Live Attenuated Vaccines for Poultry Product Overview
Table 112. PULIKE Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. PULIKE Business Overview
Table 114. PULIKE Recent Developments
Table 115. PHIBRO ANIMAL HEALTH CORPORATION Basic Information
Table 116. PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Product Overview
Table 117. PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. PHIBRO ANIMAL HEALTH CORPORATION Business Overview
Table 119. PHIBRO ANIMAL HEALTH CORPORATION Recent Developments
Table 120. JINYU BIOTECHNOLOGY Basic Information
Table 121. JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Product Overview
Table 122. JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. JINYU BIOTECHNOLOGY Business Overview
Table 124. JINYU BIOTECHNOLOGY Recent Developments
Table 125. HARBIN PHARMACEUTICAL GROUP Basic Information
Table 126. HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Product Overview
Table 127. HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. HARBIN PHARMACEUTICAL GROUP Business Overview
Table 129. HARBIN PHARMACEUTICAL GROUP Recent Developments
Table 130. MEVAC Basic Information
Table 131. MEVAC Live Attenuated Vaccines for Poultry Product Overview
Table 132. MEVAC Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. MEVAC Business Overview
Table 134. MEVAC Recent Developments
Table 135. Global Live Attenuated Vaccines for Poultry Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global Live Attenuated Vaccines for Poultry Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Live Attenuated Vaccines for Poultry Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America Live Attenuated Vaccines for Poultry Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Live Attenuated Vaccines for Poultry Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe Live Attenuated Vaccines for Poultry Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Live Attenuated Vaccines for Poultry Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific Live Attenuated Vaccines for Poultry Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Live Attenuated Vaccines for Poultry Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America Live Attenuated Vaccines for Poultry Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Live Attenuated Vaccines for Poultry Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Live Attenuated Vaccines for Poultry Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Live Attenuated Vaccines for Poultry Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global Live Attenuated Vaccines for Poultry Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Live Attenuated Vaccines for Poultry Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global Live Attenuated Vaccines for Poultry Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global Live Attenuated Vaccines for Poultry Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Live Attenuated Vaccines for Poultry Market Size by Type (M USD)
Table 4. Global Live Attenuated Vaccines for Poultry Market Size by Application
Table 5. Live Attenuated Vaccines for Poultry Market Size Comparison by Region (M USD)
Table 6. Global Live Attenuated Vaccines for Poultry Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Live Attenuated Vaccines for Poultry Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Live Attenuated Vaccines for Poultry Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Live Attenuated Vaccines for Poultry Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Vaccines for Poultry as of 2025)
Table 11. Global Market Live Attenuated Vaccines for Poultry Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Live Attenuated Vaccines for Poultry Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Live Attenuated Vaccines for Poultry Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Live Attenuated Vaccines for Poultry Sales by Type (K MT)
Table 27. Global Live Attenuated Vaccines for Poultry Market Size by Type (M USD)
Table 28. Global Live Attenuated Vaccines for Poultry Sales (K MT) by Type (2020-2025)
Table 29. Global Live Attenuated Vaccines for Poultry Sales Market Share by Type (2020-2025)
Table 30. Global Live Attenuated Vaccines for Poultry Market Size (M USD) by Type (2020-2025)
Table 31. Global Live Attenuated Vaccines for Poultry Market Share by Type (2020-2025)
Table 32. Global Live Attenuated Vaccines for Poultry Price (USD/KG) by Type (2020-2025)
Table 33. Global Live Attenuated Vaccines for Poultry Sales (K MT) by Application
Table 34. Global Live Attenuated Vaccines for Poultry Market Size by Application
Table 35. Global Live Attenuated Vaccines for Poultry Sales by Application (2020-2025) & (K MT)
Table 36. Global Live Attenuated Vaccines for Poultry Sales Market Share by Application (2020-2025)
Table 37. Global Live Attenuated Vaccines for Poultry Market Size by Application (2020-2025) & (M USD)
Table 38. Global Live Attenuated Vaccines for Poultry Market Share by Application (2020-2025)
Table 39. Global Live Attenuated Vaccines for Poultry Sales Growth Rate by Application (2020-2025)
Table 40. Global Live Attenuated Vaccines for Poultry Sales by Region (2020-2025) & (K MT)
Table 41. Global Live Attenuated Vaccines for Poultry Sales Market Share by Region (2020-2025)
Table 42. Global Live Attenuated Vaccines for Poultry Market Size by Region (2020-2025) & (M USD)
Table 43. Global Live Attenuated Vaccines for Poultry Market Size by Region (2020-2025)
Table 44. North America Live Attenuated Vaccines for Poultry Sales by Country (2020-2025) & (K MT)
Table 45. North America Live Attenuated Vaccines for Poultry Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Live Attenuated Vaccines for Poultry Sales by Country (2020-2025) & (K MT)
Table 47. Europe Live Attenuated Vaccines for Poultry Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Live Attenuated Vaccines for Poultry Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Live Attenuated Vaccines for Poultry Market Size by Region (2020-2025) & (M USD)
Table 50. South America Live Attenuated Vaccines for Poultry Sales by Country (2020-2025) & (K MT)
Table 51. South America Live Attenuated Vaccines for Poultry Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Live Attenuated Vaccines for Poultry Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Live Attenuated Vaccines for Poultry Market Size by Region (2020-2025) & (M USD)
Table 54. Global Live Attenuated Vaccines for Poultry Production (K MT) by Region(2020-2025)
Table 55. Global Live Attenuated Vaccines for Poultry Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Live Attenuated Vaccines for Poultry Revenue Market Share by Region (2020-2025)
Table 57. Global Live Attenuated Vaccines for Poultry Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Live Attenuated Vaccines for Poultry Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Live Attenuated Vaccines for Poultry Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Live Attenuated Vaccines for Poultry Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Live Attenuated Vaccines for Poultry Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. MERCK Basic Information
Table 63. MERCK Live Attenuated Vaccines for Poultry Product Overview
Table 64. MERCK Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. MERCK Business Overview
Table 66. MERCK SWOT Analysis
Table 67. MERCK Recent Developments
Table 68. Boehringer Ingelheim Basic Information
Table 69. Boehringer Ingelheim Live Attenuated Vaccines for Poultry Product Overview
Table 70. Boehringer Ingelheim Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim SWOT Analysis
Table 73. Boehringer Ingelheim Recent Developments
Table 74. ELANCO Basic Information
Table 75. ELANCO Live Attenuated Vaccines for Poultry Product Overview
Table 76. ELANCO Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. ELANCO Business Overview
Table 78. ELANCO SWOT Analysis
Table 79. ELANCO Recent Developments
Table 80. QYH BIOTECH Basic Information
Table 81. QYH BIOTECH Live Attenuated Vaccines for Poultry Product Overview
Table 82. QYH BIOTECH Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. QYH BIOTECH Business Overview
Table 84. QYH BIOTECH Recent Developments
Table 85. CEVA Basic Information
Table 86. CEVA Live Attenuated Vaccines for Poultry Product Overview
Table 87. CEVA Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. CEVA Business Overview
Table 89. CEVA Recent Developments
Table 90. HIPRA Basic Information
Table 91. HIPRA Live Attenuated Vaccines for Poultry Product Overview
Table 92. HIPRA Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. HIPRA Business Overview
Table 94. HIPRA Recent Developments
Table 95. Kemin Biologics Basic Information
Table 96. Kemin Biologics Live Attenuated Vaccines for Poultry Product Overview
Table 97. Kemin Biologics Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Kemin Biologics Business Overview
Table 99. Kemin Biologics Recent Developments
Table 100. ZOETIS Basic Information
Table 101. ZOETIS Live Attenuated Vaccines for Poultry Product Overview
Table 102. ZOETIS Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. ZOETIS Business Overview
Table 104. ZOETIS Recent Developments
Table 105. Vaxxinova Basic Information
Table 106. Vaxxinova Live Attenuated Vaccines for Poultry Product Overview
Table 107. Vaxxinova Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Vaxxinova Business Overview
Table 109. Vaxxinova Recent Developments
Table 110. PULIKE Basic Information
Table 111. PULIKE Live Attenuated Vaccines for Poultry Product Overview
Table 112. PULIKE Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. PULIKE Business Overview
Table 114. PULIKE Recent Developments
Table 115. PHIBRO ANIMAL HEALTH CORPORATION Basic Information
Table 116. PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Product Overview
Table 117. PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. PHIBRO ANIMAL HEALTH CORPORATION Business Overview
Table 119. PHIBRO ANIMAL HEALTH CORPORATION Recent Developments
Table 120. JINYU BIOTECHNOLOGY Basic Information
Table 121. JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Product Overview
Table 122. JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. JINYU BIOTECHNOLOGY Business Overview
Table 124. JINYU BIOTECHNOLOGY Recent Developments
Table 125. HARBIN PHARMACEUTICAL GROUP Basic Information
Table 126. HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Product Overview
Table 127. HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. HARBIN PHARMACEUTICAL GROUP Business Overview
Table 129. HARBIN PHARMACEUTICAL GROUP Recent Developments
Table 130. MEVAC Basic Information
Table 131. MEVAC Live Attenuated Vaccines for Poultry Product Overview
Table 132. MEVAC Live Attenuated Vaccines for Poultry Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. MEVAC Business Overview
Table 134. MEVAC Recent Developments
Table 135. Global Live Attenuated Vaccines for Poultry Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global Live Attenuated Vaccines for Poultry Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Live Attenuated Vaccines for Poultry Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America Live Attenuated Vaccines for Poultry Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Live Attenuated Vaccines for Poultry Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe Live Attenuated Vaccines for Poultry Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Live Attenuated Vaccines for Poultry Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific Live Attenuated Vaccines for Poultry Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Live Attenuated Vaccines for Poultry Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America Live Attenuated Vaccines for Poultry Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Live Attenuated Vaccines for Poultry Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Live Attenuated Vaccines for Poultry Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Live Attenuated Vaccines for Poultry Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global Live Attenuated Vaccines for Poultry Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Live Attenuated Vaccines for Poultry Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global Live Attenuated Vaccines for Poultry Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global Live Attenuated Vaccines for Poultry Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Live Attenuated Vaccines for Poultry
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Live Attenuated Vaccines for Poultry Market Size (M USD), 2025-2035
Figure 5. Global Live Attenuated Vaccines for Poultry Market Size (M USD) (2020-2035)
Figure 6. Global Live Attenuated Vaccines for Poultry Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Live Attenuated Vaccines for Poultry Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Live Attenuated Vaccines for Poultry Product Life Cycle
Figure 13. Live Attenuated Vaccines for Poultry Sales Share by Manufacturers in 2025
Figure 14. Global Live Attenuated Vaccines for Poultry Revenue Share by Manufacturers in 2025
Figure 15. Live Attenuated Vaccines for Poultry Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Live Attenuated Vaccines for Poultry Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Live Attenuated Vaccines for Poultry Revenue in 2025
Figure 18. Industry Chain Map of Live Attenuated Vaccines for Poultry
Figure 19. Global Live Attenuated Vaccines for Poultry Market PEST Analysis
Figure 20. Global Live Attenuated Vaccines for Poultry Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Live Attenuated Vaccines for Poultry Market Share by Type
Figure 27. Sales Market Share of Live Attenuated Vaccines for Poultry by Type (2020-2025)
Figure 28. Sales Market Share of Live Attenuated Vaccines for Poultry by Type in 2025
Figure 29. Market Share of Live Attenuated Vaccines for Poultry by Type (2020-2025)
Figure 30. Market Share of Live Attenuated Vaccines for Poultry by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Live Attenuated Vaccines for Poultry Market Share by Application
Figure 33. Global Live Attenuated Vaccines for Poultry Sales Market Share by Application (2020-2025)
Figure 34. Global Live Attenuated Vaccines for Poultry Sales Market Share by Application in 2025
Figure 35. Global Live Attenuated Vaccines for Poultry Market Share by Application (2020-2025)
Figure 36. Global Live Attenuated Vaccines for Poultry Market Share by Application in 2025
Figure 37. Global Live Attenuated Vaccines for Poultry Sales Growth Rate by Application (2020-2025)
Figure 38. Global Live Attenuated Vaccines for Poultry Sales Market Share by Region (2020-2025)
Figure 39. Global Live Attenuated Vaccines for Poultry Market Size by Region (2020-2025)
Figure 40. North America Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Live Attenuated Vaccines for Poultry Sales Market Share by Country in 2024
Figure 43. North America Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Live Attenuated Vaccines for Poultry Market Size by Country in 2024
Figure 45. U.S. Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Live Attenuated Vaccines for Poultry Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Live Attenuated Vaccines for Poultry Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Live Attenuated Vaccines for Poultry Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Live Attenuated Vaccines for Poultry Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Live Attenuated Vaccines for Poultry Sales Market Share by Country in 2024
Figure 53. Europe Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Live Attenuated Vaccines for Poultry Market Size by Country in 2024
Figure 55. Germany Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Live Attenuated Vaccines for Poultry Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Live Attenuated Vaccines for Poultry Sales Market Share by Region in 2024
Figure 67. Asia Pacific Live Attenuated Vaccines for Poultry Market Size by Region in 2024
Figure 68. China Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Live Attenuated Vaccines for Poultry Sales and Growth Rate (K MT)
Figure 79. South America Live Attenuated Vaccines for Poultry Sales Market Share by Country in 2024
Figure 80. South America Live Attenuated Vaccines for Poultry Market Size and Growth Rate (M USD)
Figure 81. South America Live Attenuated Vaccines for Poultry Market Size by Country in 2024
Figure 82. Brazil Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Live Attenuated Vaccines for Poultry Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Live Attenuated Vaccines for Poultry Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Live Attenuated Vaccines for Poultry Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Live Attenuated Vaccines for Poultry Market Size by Region in 2024
Figure 92. Saudi Arabia Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Live Attenuated Vaccines for Poultry Production Market Share by Region (2020-2025)
Figure 103. North America Live Attenuated Vaccines for Poultry Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Live Attenuated Vaccines for Poultry Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Live Attenuated Vaccines for Poultry Production (K MT) Growth Rate (2020-2025)
Figure 106. China Live Attenuated Vaccines for Poultry Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Live Attenuated Vaccines for Poultry Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Live Attenuated Vaccines for Poultry Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Live Attenuated Vaccines for Poultry Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Live Attenuated Vaccines for Poultry Market Share Forecast by Type (2026-2035)
Figure 111. Global Live Attenuated Vaccines for Poultry Sales Forecast by Application (2026-2035)
Figure 112. Global Live Attenuated Vaccines for Poultry Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Live Attenuated Vaccines for Poultry
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Live Attenuated Vaccines for Poultry Market Size (M USD), 2025-2035
Figure 5. Global Live Attenuated Vaccines for Poultry Market Size (M USD) (2020-2035)
Figure 6. Global Live Attenuated Vaccines for Poultry Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Live Attenuated Vaccines for Poultry Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Live Attenuated Vaccines for Poultry Product Life Cycle
Figure 13. Live Attenuated Vaccines for Poultry Sales Share by Manufacturers in 2025
Figure 14. Global Live Attenuated Vaccines for Poultry Revenue Share by Manufacturers in 2025
Figure 15. Live Attenuated Vaccines for Poultry Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Live Attenuated Vaccines for Poultry Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Live Attenuated Vaccines for Poultry Revenue in 2025
Figure 18. Industry Chain Map of Live Attenuated Vaccines for Poultry
Figure 19. Global Live Attenuated Vaccines for Poultry Market PEST Analysis
Figure 20. Global Live Attenuated Vaccines for Poultry Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Live Attenuated Vaccines for Poultry Market Share by Type
Figure 27. Sales Market Share of Live Attenuated Vaccines for Poultry by Type (2020-2025)
Figure 28. Sales Market Share of Live Attenuated Vaccines for Poultry by Type in 2025
Figure 29. Market Share of Live Attenuated Vaccines for Poultry by Type (2020-2025)
Figure 30. Market Share of Live Attenuated Vaccines for Poultry by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Live Attenuated Vaccines for Poultry Market Share by Application
Figure 33. Global Live Attenuated Vaccines for Poultry Sales Market Share by Application (2020-2025)
Figure 34. Global Live Attenuated Vaccines for Poultry Sales Market Share by Application in 2025
Figure 35. Global Live Attenuated Vaccines for Poultry Market Share by Application (2020-2025)
Figure 36. Global Live Attenuated Vaccines for Poultry Market Share by Application in 2025
Figure 37. Global Live Attenuated Vaccines for Poultry Sales Growth Rate by Application (2020-2025)
Figure 38. Global Live Attenuated Vaccines for Poultry Sales Market Share by Region (2020-2025)
Figure 39. Global Live Attenuated Vaccines for Poultry Market Size by Region (2020-2025)
Figure 40. North America Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Live Attenuated Vaccines for Poultry Sales Market Share by Country in 2024
Figure 43. North America Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Live Attenuated Vaccines for Poultry Market Size by Country in 2024
Figure 45. U.S. Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Live Attenuated Vaccines for Poultry Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Live Attenuated Vaccines for Poultry Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Live Attenuated Vaccines for Poultry Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Live Attenuated Vaccines for Poultry Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Live Attenuated Vaccines for Poultry Sales Market Share by Country in 2024
Figure 53. Europe Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Live Attenuated Vaccines for Poultry Market Size by Country in 2024
Figure 55. Germany Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Live Attenuated Vaccines for Poultry Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Live Attenuated Vaccines for Poultry Sales Market Share by Region in 2024
Figure 67. Asia Pacific Live Attenuated Vaccines for Poultry Market Size by Region in 2024
Figure 68. China Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Live Attenuated Vaccines for Poultry Sales and Growth Rate (K MT)
Figure 79. South America Live Attenuated Vaccines for Poultry Sales Market Share by Country in 2024
Figure 80. South America Live Attenuated Vaccines for Poultry Market Size and Growth Rate (M USD)
Figure 81. South America Live Attenuated Vaccines for Poultry Market Size by Country in 2024
Figure 82. Brazil Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Live Attenuated Vaccines for Poultry Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Live Attenuated Vaccines for Poultry Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Live Attenuated Vaccines for Poultry Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Live Attenuated Vaccines for Poultry Market Size by Region in 2024
Figure 92. Saudi Arabia Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Live Attenuated Vaccines for Poultry Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Live Attenuated Vaccines for Poultry Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Live Attenuated Vaccines for Poultry Production Market Share by Region (2020-2025)
Figure 103. North America Live Attenuated Vaccines for Poultry Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Live Attenuated Vaccines for Poultry Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Live Attenuated Vaccines for Poultry Production (K MT) Growth Rate (2020-2025)
Figure 106. China Live Attenuated Vaccines for Poultry Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Live Attenuated Vaccines for Poultry Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Live Attenuated Vaccines for Poultry Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Live Attenuated Vaccines for Poultry Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Live Attenuated Vaccines for Poultry Market Share Forecast by Type (2026-2035)
Figure 111. Global Live Attenuated Vaccines for Poultry Sales Forecast by Application (2026-2035)
Figure 112. Global Live Attenuated Vaccines for Poultry Market Share Forecast by Application (2026-2035)
